The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-κB-dependent XIAP Up-Regulation
Open accessAbstract
The aggressiveness of a tumor is partly attributed to its resistance to chemotherapeutic agent-induced apoptosis. Cysteine-rich 61 (Cyr61), from the CCN gene family, is a secreted and matrix-associated protein, which is involved in many cellular activities such as growth and differentiation. Here we established a cell model system to examine whether stable expression of Cyr61 in MCF-7 cells can confer resistance to apoptosis and identify possible participating mechanisms. We showed that stable cell lines overexpressing Cyr61 had acquired a remarkable resistance to apoptosis induced by paclitaxel, adriamycin, and β-lapachone. Most interesting, gel shift and reporter assays showed that the Cyr61-overexpressing cells had significantly increased NF-κB activity compared with neo control cells. Blockage of NF-κB activity in Cyr61-expressing cells by transfecting with a dominant negative (DN)-IκB or with an NF-κB decoy rendered them more susceptible to anti-cancer drugs-induced apoptosis. In addition, several NF-κB-regulated anti-apoptotic genes were examined, and we found that only XIAP showed a significant 3–4-fold increase in mRNA and protein in Cyr61-overexpressing cells but not in neo control cells. Treatment with inhibitor of apoptosis protein (XIAP)-specific antisense, but not sense, oligonucleotides abolished the apoptosis resistance of the Cyr61-overexpressing cells. At the same time, transfection of these stable cells with DN-IκB to block NF-κB activity also effectively reduced the elevated XIAP level. Function-neutralizing antibodies to αvβ3 and αvβ5 could inhibit Cyr61-mediated NF-κB activation as well as XIAP expression. Taken together, our data suggested that Cyr61 plays an important role in resistance to chemotherapeutic agent-induced apoptosis in human breast cancer MCF-7 cells by a mechanism involving the activation of the integrins/NF-κB/XIAP signaling pathway. The aggressiveness of a tumor is partly attributed to its resistance to chemotherapeutic agent-induced apoptosis. Cysteine-rich 61 (Cyr61), from the CCN gene family, is a secreted and matrix-associated protein, which is involved in many cellular activities such as growth and differentiation. Here we established a cell model system to examine whether stable expression of Cyr61 in MCF-7 cells can confer resistance to apoptosis and identify possible participating mechanisms. We showed that stable cell lines overexpressing Cyr61 had acquired a remarkable resistance to apoptosis induced by paclitaxel, adriamycin, and β-lapachone. Most interesting, gel shift and reporter assays showed that the Cyr61-overexpressing cells had significantly increased NF-κB activity compared with neo control cells. Blockage of NF-κB activity in Cyr61-expressing cells by transfecting with a dominant negative (DN)-IκB or with an NF-κB decoy rendered them more susceptible to anti-cancer drugs-induced apoptosis. In addition, several NF-κB-regulated anti-apoptotic genes were examined, and we found that only XIAP showed a significant 3–4-fold increase in mRNA and protein in Cyr61-overexpressing cells but not in neo control cells. Treatment with inhibitor of apoptosis protein (XIAP)-specific antisense, but not sense, oligonucleotides abolished the apoptosis resistance of the Cyr61-overexpressing cells. At the same time, transfection of these stable cells with DN-IκB to block NF-κB activity also effectively reduced the elevated XIAP level. Function-neutralizing antibodies to αvβ3 and αvβ5 could inhibit Cyr61-mediated NF-κB activation as well as XIAP expression. Taken together, our data suggested that Cyr61 plays an important role in resistance to chemotherapeutic agent-induced apoptosis in human breast cancer MCF-7 cells by a mechanism involving the activation of the integrins/NF-κB/XIAP signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CCN1 promotes the survival of endothelial cells through integrin αvβ3 [72], and inhibits apoptosis by activation of Akt in pulmonary epithelial cells [80] or upregulation of XIAP in MCF7 breast cancer cells [81].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [81]
In the citing paper
“Although CCN1 promotes cell survival in endothelial cells and some cancer cells [72,81], it represents the first example of an ECM molecule that can induce apoptosis through the process cell adhesion [61].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [81]
In the citing paper
“The anti-apoptotic functions of CCN1 in breast cancer cells are mediated through its receptor integrin αvβ3 [81,153], whose expression is also induced by CCN1 [154].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [81]
In the citing paper
“In MCF7 breast cancer cells, which are dependent on estrogen for growth, overexpression of CCN1 renders these cells estrogen-independent and significantly resistant to apoptosis, in part through upregulation of the anti-apoptotic protein XIAP [81,152,153].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [81]
In the citing paper
“In MCF7 breast cancer cells, which are dependent on estrogen for growth, overexpression of CCN1 renders these cells estrogen-independent and significantly resistant to apoptosis, in part through upregulation of the anti-apoptotic protein XIAP [81,152,153].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chawla‐Sarkar, M., Bauer, J. A., Lupica, J. A., Morrison, B., Tang, Z., Oates, R. K., Almasan, A., DiDonato, J. A., Borden, E. C., & Lindner, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306111200 · Cited by 77
RetractedA multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,605
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1209 · Cited by 2,218
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,889
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,427
The inhibitors of apoptosis (IAPs) and their emerging role in cancer
LaCasse, E. C., Baird, S. D., Korneluk, R. G., & MacKenzie, A. (1998) · Oncogene · doi:10.1038/sj.onc.1202569 · Cited by 980
Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β
Abreu, J. G., Ketpura, N. I., Reversade, B., & Robertis, E. M. D. (2002) · Nature Cell Biology · doi:10.1038/ncb826 · Cited by 901
Apoptosis and melanoma chemoresistance
Soengas, M. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206454 · Cited by 836
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Kucharczak, J., Simmons, M. J., Fan, Y., & Gélinas, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207230 · Cited by 773
Flagged first, then by citations
Research works printed but not linked: 8
- O'Brien, 1990, Mol. Cell. Biol., 10, 3569
- Xie, 2001, Cancer Res., 61, 8917
- Romieu-Mourez, 2002, Cancer Res., 62, 6770
- Grzeszkiewicz, 2002, Endocrinology, 143, 1441, 10.1210/endo.143.4.8731 · DOI · Paper page
- Tsai, 2000, Cancer Res., 60, 5603
- Qi, 2003, Cancer Res., 63, 7076
- Kikuchi, 2003, Cancer Res., 63, 107
- Yang, 2003, Cancer Res., 63, 6815
Cited by
Sorted by citations
NF-κB activation as a pathological mechanism of septic shock and inflammation
Liu, S. F., & Malik, A. B. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00477.2005 · Cited by 769
Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Jun, J.-I., & Lau, L. F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3599 · Cited by 568
Functions and mechanisms of action of CCN matricellular proteins
Chen, C.-C., & Lau, L. F. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.025 · Cited by 549
Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas
Hoek, K. S., Rimm, D. L., Williams, K. R., Zhao, H., Ariyan, S., Lin, A., Kluger, H. M., Berger, A. J., Cheng, E., Trombetta, E. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0731 · Cited by 494
YAP/TAZ Signaling and Resistance to Cancer Therapy
Nguyen, C. D. K., & Yi, C. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.02.010 · Cited by 437
Lai, D., Ho, K. C., Hao, Y., & Yang, X. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2711 · Cited by 416
Expression profiling reveals novel pathways in the transformation of Melanocytes to Melanomas.
Hoek, K. S., Rimm, D. L., Williams, K. R., Zhao, H., Ariyan, S., Lin, A. J., Kluger, H. M., Berger, A. J., Cheng, E., Trombetta, E. S., et al. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00175_12.x · Cited by 412
CCN1/CYR61: the very model of a modern matricellular protein
Lau, L. F. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0778-3 · Cited by 338
Piccaluga, P. P., Agostinelli, C., Califano, A., Rossi, M., Basso, K., Zupo, S., Went, P., Klein, U., Zinzani, P. L., Baccarani, M., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci26833 · Cited by 307
Natural Products for the Management and Prevention of Breast Cancer
Mitra, S., & Dash, R. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/8324696 · Cited by 254
Lee, M.-C. W., López-Díaz, F. J., Khan, S. Y., Tariq, M., Dayn, Y., Vaske, C. J., Radenbaugh, A., Kim, H. J., Emerson, B. M., & Pourmand, N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404656111 · Cited by 174
Functional properties and intracellular signaling of CCN1/Cyr61
Chen, Y., & Du, X. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21194 · Cited by 169
Curcumin in Treating Breast Cancer: A Review
Wang, Y., Yu, J., Cui, R., Lin, J.-J., & Ding, X. (2016) · SLAS TECHNOLOGY · doi:10.1177/2211068216655524 · Cited by 162
Menendez, J. A., Vellon, L., Mehmi, I., Teng, P. K., Griggs, D. W., & Lupu, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208238 · Cited by 154
Chen, P., Wang, M.-Y., Wu, S.-N., Su, J.-L., Hong, C., Chuang, S., Chen, M.-W., Hua, K., Wu, Y.-L., Cha, S.-T., et al. (2007) · Journal of Cell Science · doi:10.1242/jcs.03460 · Cited by 151
Self-citationMatricellular Proteins: A Sticky Affair with Cancers
Chong, H. C., Tan, C. K., Huang, R.-L., & Tan, N. S. (2012) · Journal of Oncology · doi:10.1155/2012/351089 · Cited by 146
The Evolution of Antibodies into Versatile Tumor-Targeting Agents
Lin, M. Z., Teitell, M. A., & Schiller, G. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.129.11.1 · Cited by 137
Self-citationThe matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts
Todorovicç, V., Chen, C.-C., Hay, N., & Lau, L. F. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504015 · Cited by 132
STAT3 inhibitors for cancer therapy
Fagard, R., Metelev, V., Souissi, I., & Baran‐Marszak, F. (2013) · JAK-STAT · doi:10.4161/jkst.22882 · Cited by 131
Hou, C., Lin, F.-L., Hou, S.-M., & Liu, J. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-236 · Cited by 131
Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes
Piccaluga, P. P., Falco, G. D., Kustagi, M., Gazzola, A., Agostinelli, C., Tripodo, C., Leucci, E., Onnis, A., Astolfi, A., Sapienza, M. R., et al. (2011) · Blood · doi:10.1182/blood-2010-08-301556 · Cited by 128
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
Ciamporcero, E. S., Shen, H., Ramakrishnan, S., Ku, S., Chintala, S., Shen, L., Adelaiye-Ogala, R. M., Miles, K. M., Ullio, C., Pizzimenti, S., et al. (2015) · Oncogene · doi:10.1038/onc.2015.219 · Cited by 126
Monnier, Y., Farmer, P., Bieler, G., Imaizumi, N., Sengstag, T., Alghisi, G. C., Stehle, J.-C., Ciarloni, L., Andrejevic-Blant, S., Moeckli, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0841 · Cited by 123
Su, J.-L., Chiou, J., Tang, C.-H., Zhao, M., Tsai, C.-H., Chen, P.-S., Chang, Y.-W., Chien, M.-H., Peng, C.-Y., Hsiao, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.087122 · Cited by 121
Self-citationHaque, I., Mehta, S., Majumder, M., Dhar, K., De, A., McGregor, D., Van Veldhuizen, P. J., Banerjee, S. K., & Banerjee, S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-8 · Cited by 113
Lee, H.-Y., Chung, J.-W., Youn, S.-W., Kim, J.-Y., Park, K.-W., Koo, B.-K., Oh, B.-H., Park, Y.-B., Chaqour, B., Walsh, K., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000257945.97958.77 · Cited by 107
Hesler, R., Huang, J. J., Starr, M. D., Treboschi, V. M., Bernanke, A., Nixon, A. B., McCall, S. J., White, R. R., & Blobe, G. C. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw093 · Cited by 105
Lin, S., Chien, C., Lee, J., Yeh, Y.-C., Hsu, K., Lai, Y.-Y., Lin, S.-C., & Tsai, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44362 · Cited by 104
The CCN family proteins in carcinogenesis.
Dhar, A., & Ray, A. (2010) · PubMed · Cited by 97
αVβ3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer
Vellon, L., Menendez, J. A., & Lupu, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208452 · Cited by 98
Phytotherapy and Nutritional Supplements on Breast Cancer
Lopes, C. M., Dourado, Á. W. A., & Oliveira, R. (2017) · BioMed Research International · doi:10.1155/2017/7207983 · Cited by 104
Gery, S., Xie, D., Yin, D., Gabra, H., Miller, C., Wang, H., Scott, D., Yi, W. S., Popoviciu, M. L., Said, J. W., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0231 · Cited by 97
CCN proteins and cancer: two to tango
Bleau, A. (2005) · Frontiers in bioscience · doi:10.2741/1594 · Cited by 97
Cyr61 Suppresses Growth of Human Endometrial Cancer Cells
Chien, W., Kumagai, T., Miller, C. W., Desmond, J. C., Frank, J. M., Said, J. W., & Koeffler, H. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410254200 · Cited by 96
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
Sun, Z.-J., Wang, Y., Cai, Z., Chen, P.-P., Tong, X.-J., & Xie, D. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604712 · Cited by 95
Wang, L., Guo, H., Yang, L., Dong, L., Lin, C., Zhang, J., Lin, P., & Wang, X. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1621-y · Cited by 93
Morusin induces apoptosis and suppresses NF-κB activity in human colorectal cancer HT-29 cells
Lee, J., Won, S., Chao, C.-L., Wu, F.-L., Liu, H., Ling, P., Lin, C.-N., & Su, C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.023 · Cited by 93
Magbanua, M. J. M., Wolf, D. M., Yau, C. S. F., Davis, S., Crothers, J., Au, A., Haqq, C. M., Livasy, C., Rugo, H. S., I-SPY 1 TRIAL Investigators, et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0582-3 · Cited by 97
Lin, M.-T., Zuon, C.-Y., Chang, C.-C., Chen, S., Chen, C., Lin, B., Wang, M., Jeng, Y., Chang, K., Lee, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2639 · Cited by 93
Self-citationThe Hippo Signaling Pathway in Drug Resistance in Cancer
Zeng, R., & Dong, J. (2021) · Cancers · doi:10.3390/cancers13020318 · Cited by 89
Roy, K., Kanwar, R. K., & Kanwar, J. R. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.055 · Cited by 88
Alternative Splicing of Cyr61 Is Regulated by Hypoxia and Significantly Changed in Breast Cancer
Hirschfeld, M., zur Hausen, A., Bettendorf, H., Jäger, M., & Stickeler, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1997 · Cited by 86
SOX4: Joining the Master Regulators of Epithelial-to-Mesenchymal Transition?
Lourenço, A. R., & Coffer, P. J. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.06.002 · Cited by 81
Lee, K.-B., Byun, H., Park, S. H., Park, C.-Y., Lee, S., & Rho, S. B. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.016 · Cited by 77
Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells
Vidot, S., Witham, J., Agarwal, R., Greenhough, S., Bamrah, H. S., Tigyi, G., Kaye, S. B., & Richardson, A. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.01.017 · Cited by 75
Th, W., Chan, Y.-H., Chen, C., Kung, W.-H., Lee, Y.-S., Wang, S., Chang, T.-C., & Wang, H. (2006) · Oncogene · doi:10.1038/sj.onc.1209498 · Cited by 75
Tan, T., Yang, W.-H., Lin, Y.-T., Hsu, S.-F., Li, T.-M., Kao, S.-T., Chen, W., Fong, Y., & Tang, C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgn284 · Cited by 72
DAPk1 inhibits NF-κB activation through TNF-α and INF-γ-induced apoptosis
Yoo, H. J., Byun, H.-J., Kim, B.-R., Lee, K. H., Park, S., & Rho, S. B. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.03.010 · Cited by 73
The Ambivalent Function of YAP in Apoptosis and Cancer
Zhang, X., Abdelrahman, A., Vollmar, B., & Zechner, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123770 · Cited by 71
Zhou, D., Herrick, D. J., Rosenbloom, J., & Chaqour, B. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01093.2004 · Cited by 72
Yang, J., Li, H., Chen, Y., Wang, X., Shi, G., Hu, Q.-S., Kang, X., Lü, Y., Tang, X., Guo, Q.-S., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.016 · Cited by 70
Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence
Kan, T., Zhang, S., Zhou, S., Ya, Z., Zhao, Y., Gao, Y.-H., Zhang, T., Gao, F., Wang, X., Zhao, L., et al. (2022) · Oncogene · doi:10.1038/s41388-021-02139-z · Cited by 67
Lin, M., Kuo, I., Chang, C.-C., Chu, C., Chen, H., Lin, B., Sureshbabu, M., Shih, H.-J., & Kuo, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708933200 · Cited by 67
Self-citationRetractedHormesis: Wound healing and keratinocytes
Calabrese, E. J., Dhawan, G., Kapoor, R., Agathokleous, E., & Calabrese, V. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106393 · Cited by 66
CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity
Park, M.-H., Kim, A. K., Manandhar, S., Oh, S.-Y., Jang, G.-H., Kang, L., Lee, D., Hyeon, D. Y., Lee, S.-H., Lee, H., et al. (2019) · eLife · doi:10.7554/elife.46012 · Cited by 62
TRIM proteins in hepatocellular carcinoma
Lu, K., Pan, Y., Huang, Z., Liang, H., Ding, Z., & Zhang, B. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00854-7 · Cited by 66
Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies
Agostinelli, C., Piccaluga, P. P., Went, P., Rossi, M., Gazzola, A., Righi, S., Sista, T., Campidelli, C., Zinzani, P. L., Falini, B., et al. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.055335 · Cited by 65
WISP-1 increases MMP-2 expression and cell motility in human chondrosarcoma cells
Hou, C., Chiang, Y.-C., Fong, Y., & Tang, C. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.03.016 · Cited by 62
In vitro and in vivo wound healing-promoting activities of β-lapachone
Kung, H., Yang, M.-J., Chang, C., Chau, Y., & Lu, K. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00266.2008 · Cited by 61
Self-citationYang, Y., Zhou, X., Xu, M., Piao, J., Zhang, Y., Lin, Z., & Chen, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-02937-0 · Cited by 61
CCN1 protects cardiac myocytes from oxidative stress via β1 integrin–Akt pathway
Yoshida, Y., Togi, K., Matsumae, H., Nakashima, Y., Kojima, Y., Yamamoto, H., Ono, K., Nakamura, T., Kita, T., & Tanaka, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.195 · Cited by 59
Evans, M. K., Brown, M. C., Geradts, J., Bao, X., Robinson, T. J., Jolly, M. K., Vermeulen, P. B., Palmer, G. M., Gromeier, M., Levine, H., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1667 · Cited by 59
CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis
Fromigué, O., Hamidouche, Z., Vaudin, P., Lecanda, F., Patiño‐García, A., Barbry, P., Mari, B. P., & Marie, P. J. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.343 · Cited by 58
Crockett, J. C., Schütze, N., Tosh, D., Jatzke, S., Duthie, A., Jakob, F., & Rogers, M. J. (2007) · Endocrinology · doi:10.1210/en.2007-0473 · Cited by 57
Hypoxia-regulated gene network in drug resistance and cancer progression
Lin, S.-C., Liao, W.-L., Lee, J., & Tsai, S. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214532755 · Cited by 58
Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells
Collett, G. P., & Campbell, F. C. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi368 · Cited by 55
Villeneuve, D. J., Hembruff, S. L., Veitch, Z. W. N., Cecchetto, M., Dew, W. A., & Parissenti, A. M. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9026-6 · Cited by 58
Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cells
Liu, Z., Li, H., Wu, X., Yoo, B. H., Yan, S. R., Stadnyk, A. W., Sasazuki, T., Shirasawa, S., LaCasse, E. C., Korneluk, R. G., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209753 · Cited by 54
Lee, H., Youn, S., Kim, J., Park, K. W., Hwang, C., Park, W., Oh, B., Park, Y.-B., Walsh, K. X., Seo, J., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.153304 · Cited by 53
Lin, B.-R., Chang, C.-C., Chen, L.-R., Wu, M.-H., Wang, M.-Y., Kuo, I.-H., Chu, C.-Y., Chang, K.-J., Lee, P.-H., Chen, W.-J., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0289 · Cited by 51
Self-citationZhu, X., Wu, Y., Miao, X., Li, C., Yin, H., Yang, S., Lu, X., Liu, Y., Chen, Y., Shen, R., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5316-3 · Cited by 51
Lin, M., Chang, C.-C., Lin, B., Yang, H., Chu, C., Wu, M., & Kuo, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706600200 · Cited by 52
Self-citationEffects of reduced frequency of milk removal on gene expression in the bovine mammary gland
Littlejohn, M. D., Walker, C. G., Ward, H. E., Lehnert, K., Snell, R. G., Verkerk, G. A., Spelman, R. J., Clark, D. A., & Davis, S. R. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.00108.2009 · Cited by 54
Park, J.-H., Liu, L., Kim, I.-H., Kim, J.-H., You, K.-R., & Kim, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2221 · Cited by 49
Cyr61 Protects against Hyperoxia-Induced Cell Death via Akt Pathway in Pulmonary Epithelial Cells
Jin, Y., Kim, H. P., Ifedigbo, E., Lau, L. F., & Choi, A. M. K. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0144oc · Cited by 48
YAP regulates cell size and growth dynamics via non-cell autonomous mediators
Mugahid, D., Kalocsay, M., Liu, X., Gruver, J. S., Peshkin, L., & Kirschner, M. W. (2020) · eLife · doi:10.7554/elife.53404 · Cited by 52
Yao, L., Zhang, Y., Chen, K., Hu, X., & Xu, L. X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024684 · Cited by 51
A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo
Lin, J., Huo, R., Wang, L., Zhou, Z., Sun, Y., Shen, B., Wang, R., & Li, N. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1135-y · Cited by 47
Gearhart-Serna, L., Davis, J. B., Jolly, M. K., Jayasundara, N., Sauer, S. J., Giulio, R. T. D., & Devi, G. R. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa047 · Cited by 46
Mao, Z., Ma, X., Rong, Y., Cui, L., Wang, X., Wu, W., Zhang, J., & Jin, D. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01746.x · Cited by 46
Lee, H., Hwang, S. J., Kim, H. R., Shin, C. H., Choi, K. H., Joung, J., & Kim, H. H. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.02.010 · Cited by 45
Quercetin Suppresses CYR61-Mediated Multidrug Resistance in Human Gastric Adenocarcinoma AGS Cells
Hyun, H. B., Moon, J., & Cho, S. K. (2018) · Molecules · doi:10.3390/molecules23020209 · Cited by 45
G Protein-Coupled Receptors Go Extracellular: RhoA Integrates the Integrins
Walsh, C. T., Stupack, D., & Brown, J. H. (2008) · Molecular Interventions · doi:10.1124/mi.8.4.8 · Cited by 40
Wu, C., Tsai, H., Chen, Z., Wu, C., Li, T., Fong, Y., & Tang, C. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.09.005 · Cited by 43
Chuang, J., Chang, A., Chiang, I., Tsai, M., & Tang, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078022 · Cited by 41
New molecular insights into peripheral T cell lymphomas
Pileri, S. A., & Piccaluga, P. P. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61205 · Cited by 41
Sun, S., Li, F., Gao, X., Zhu, Y., Chen, J., Zhu, X., Yuan, H., & Gao, D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.054 · Cited by 41
Expression, purification, and functional testing of recombinant CYR61/CCN1
Schütze, N., Kunzi‐Rapp, K., Wagemanns, R., Nöth, U. A., Jatzke, S., & Jakob, F. J. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.03.031 · Cited by 42
You, J.-J., Yang, C., Chen, M., & Yang, C. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2603 · Cited by 39
Sung, B., Pandey, M. K., Nakajima, Y., Nishida, H., Konishi, T., Chaturvedi, M. M., & Aggarwal, B. B. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0406 · Cited by 39
Syam, S., Bustamam, A., Abdullah, R., Sukari, M. A., Hashim, N. M., Ghaderian, M., Rahmani, M., Mohan, S., Abdelwahab, S. İ., & Ali, H. M. (2013) · Journal of Functional Foods · doi:10.1016/j.jff.2013.10.018 · Cited by 37
CYR61 (CCN1) overexpression induces lung injury in mice
Grazioli, S., Gil, S., An, D., Kajikawa, O., Farnand, A. W., Hanson, J. F., Birkland, T. P., Chen, P., Duffield, J. S., Schnapp, L. M., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00190.2014 · Cited by 37
Vellón, L., Menéndez, J. A., & Lupu, R. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20242 · Cited by 38
Long, X., Yu, Y., Perlaky, L., Man, T., & Redell, M. S. (2015) · British Journal of Haematology · doi:10.1111/bjh.13492 · Cited by 35
Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction
Chen, L., Xiong, Y., Xu, J., Wang, J., Meng, Z., & Hong, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.21317 · Cited by 34
Henley, D. C., Isbill, M., Fernando, R., Foster, J. S., & Wimalasena, J. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0262-1 · Cited by 35
Extracellular Matrix Associated Protein CYR61 is Linked to Prostate Cancer Development
D'Antonio, K. B., Toubaji, A., Albadine, R., Mondul, A. M., Platz, E. A., Netto, G. J., & Getzenberg, R. H. (2010) · Journal of Urology · doi:10.1016/j.juro.2009.12.006 · Cited by 34
Gordon, A. H., O’Keefe, R. J., Schwarz, E. M., Rosier, R. N., & Puzas, J. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4017 · Cited by 33
Watari, H., Xiong, Y., Hassan, M. K., & Sakuragi, N. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.09.039 · Cited by 30
Cras, A., Politis, B., Balitrand, N., Darsin-Bettinger, D., Boëlle, P., Cassinat, B., Toubert, M., & Chomienne, C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0510 · Cited by 31
Metadata
- Authors
- Lin, M.-T., Chang, C.-C., Chen, S.-T., Chang, H.-L., Su, J.-L., Chau, Y.-P., & Kuo, M.-L.
- Affiliations
- National Taiwan University Hospital (TW)
- National Taiwan University (TW)
- National Health Research Institutes (TW)
- National Yang Ming University (TW)
- Corresponding author
- Kuo, Min-Liang
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 279
- Issue
- 23
- Pages
- 24015-24023
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1983777512
- Cited by
- 194
- References
- 86
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 12 · 2021: 9 · 2020: 5 · 2019: 5 · 2018: 8 · 2017: 9 · 2016: 10 · 2015: 8 · 2014: 8 · 2013: 9 · 2012: 11
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Science Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- CYR61, CCN family, apoptosis resistance, breast cancer, MCF-7 cells, NF-κB, XIAP, chemoresistance, integrins, integrin αvβ3, paclitaxel, doxorubicin, β-lapachone, antisense oligonucleotides, anti-apoptotic genes
- MeSH terms
- Antibiotics, Antineoplastic, Antineoplastic Agents, Phytogenic, Breast Neoplasms, Cell Division, Cell Nucleus, Cell Survival, DNA, Doxorubicin, Flow Cytometry, Genes, Dominant, Humans, Microscopy, Fluorescence, Models, Biological, Naphthoquinones, Promoter Regions, Genetic, Proteins, RNA, Messenger, Time Factors, Transfection, Blotting, Western, Signal Transduction, Up-Regulation, Integrins, NF-kappa B, Oligonucleotides, Antisense, Apoptosis, Paclitaxel, Immediate-Early Proteins, Genes, Reporter, Receptors, Vitronectin, Reverse Transcriptase Polymerase Chain Reaction, Active Transport, Cell Nucleus, Intercellular Signaling Peptides and Proteins, Integrin alphaVbeta3, Cell Line, Tumor, X-Linked Inhibitor of Apoptosis Protein, Cysteine-Rich Protein 61
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review